Efficacy and Safety of Polatuzumab-Vedotin Plus Rituximab, Cyclophosphamide, Doxorubicin and Prednisone (Pola-R-CHP) for Diffuse Large B-Cell Lymphoma in the Real-World Setting: A Single Institute Retrospective Study
- Resource Type
- Abstract
- Source
- In
Blood 2 November 2023 142 Supplement 1:3107-3107 - Subject
- Language
- ISSN
- 0006-4971